Butalbital is not suggested as a first-line treatment for headache because it impairs alertness, brings risk of dependence and addiction, and increases the risk that episodic headaches will become chronic [REF].
There are specific treatments which are appropriate for targeting migraines and headaches which are preferable to butalbital when available as an option [REF].